{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:57:56Z","timestamp":1774565876055,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1053\/pcad.2002.129975","type":"journal-article","created":{"date-parts":[[2003,1,13]],"date-time":"2003-01-13T20:41:29Z","timestamp":1042490489000},"page":"225-234","source":"Crossref","is-referenced-by-count":76,"title":["Pulmonary hypertension associated with connective tissue disease"],"prefix":"10.1053","volume":"45","author":[{"given":"Karen A.","family":"Fagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Badesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/pcad.2002.129975_bib1","first-page":"1038","article-title":"Pulmonary arterial histology and morphometry in systemic sclerosis: A case-control autopsy study","volume":"16","author":"al-Sabbagh","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9343(78)90455-2","article-title":"Pulmonary vascular changes in scleroderma","volume":"64","author":"Young","year":"1978","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0272-5231(05)70112-X","article-title":"Manifestations of scleroderma pulmonary disease","volume":"19","author":"Minai","year":"1998","journal-title":"Clin Chest Med"},{"key":"10.1053\/pcad.2002.129975_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005382-199203000-00005","article-title":"Pulmonary manifestations of scleroderma","volume":"7","author":"Arroliga","year":"1992","journal-title":"J Thorac Imaging"},{"key":"10.1053\/pcad.2002.129975_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients","volume":"35","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1378\/chest.110.6.1515","article-title":"Prevalence of pulmonary hypertension in limited and diffuse scleroderma","volume":"110","author":"Battle","year":"1996","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/rheumatology\/33.12.1117","article-title":"Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies","volume":"33","author":"van den Hoogen","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-86-4-394","article-title":"Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)","volume":"86","author":"Salerni","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.129975_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/art.1780240615","article-title":"Increased prevalence of DRw3 in the CREST syndrome","volume":"24","author":"Germain","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(83)91169-5","article-title":"Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis","volume":"75","author":"Ungerer","year":"1983","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0046-8177(90)90002-M","article-title":"The pulmonary pathologic manifestations of the CREST syndrome","volume":"21","author":"Yousem","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1053\/pcad.2002.129975_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/rheumatology\/40.4.453","article-title":"Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival","volume":"40","author":"MacGregor","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/pcad.2002.129975_bib14","first-page":"639","article-title":"Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: Association with serum anti-U3RNP antibody","volume":"23","author":"Sacks","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9343(05)80004-X","article-title":"Failure of vasoldilator infusion to alter pulmonary diffusing capacity in systemic sclerosis","volume":"90","author":"Thurm","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.129975_bib17","first-page":"1292","article-title":"Pulmonary hypertension in a lupus clinic: Experience with twenty-four patients","volume":"17","author":"Asherson","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/000331978503600705","article-title":"Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients","volume":"36","author":"Badui","year":"1985","journal-title":"Angiology"},{"key":"10.1053\/pcad.2002.129975_bib19","first-page":"1923","article-title":"Pulmonary hypertension in systemic lupus erythematosus: Clinical association and survival in 18 patients","volume":"26","author":"Li","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-857X(21)00230-1","article-title":"Pleuropulmonary manifestations of systemic lupus erythematosus","volume":"20","author":"Orens","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/pcad.2002.129975_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002960050074","article-title":"Wang. 1999. Pulmonary hypertension in systemic lupus erythematosus","volume":"18","author":"Shen","year":"1999","journal-title":"Rheumatol Int"},{"key":"10.1053\/pcad.2002.129975_bib22","first-page":"918","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"16","author":"Simonson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib23","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: Evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: Anticardiolipin and anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.129975_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-5231(05)70113-1","article-title":"Respiratory complications in mixed connective tissue disease","volume":"19","author":"Prakash","year":"1998","journal-title":"Clin Chest Med"},{"key":"10.1053\/pcad.2002.129975_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00002281-199511000-00017","article-title":"Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions","volume":"7","author":"Kallenberg","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/rheumatology\/31.12.811","article-title":"Clinical manifestations and anti-(U1)snRNP antibodies: A prospective study of 29 anti-RNP antibody positive patients","volume":"31","author":"Lundberg","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00005792-198403000-00003","article-title":"A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease","volume":"63","author":"Sullivan","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/pcad.2002.129975_bib30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","article-title":"Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings","volume":"42","author":"Burdt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib31","first-page":"499","article-title":"Severe pulmonary involvement in mixed connective tissue disease","volume":"124","author":"Wiener-Kronish","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/pcad.2002.129975_bib32","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/rheumatology\/39.12.1320","article-title":"Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients","volume":"39","author":"Dawson","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/pcad.2002.129975_bib33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780221007","article-title":"Cardiac involvement in polymyositis: A clinicopathologic study of 20 autopsied patients","volume":"22","author":"Denbow","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib34","first-page":"1563","article-title":"Left ventricular diastolic function in systemic sclerosis","volume":"28","author":"Aguglia","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002281-200111000-00008","article-title":"The heart and pulmonary vasculature in scleroderma: Clinical features and pathobiology","volume":"13","author":"Coghlan","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.59.2.94","article-title":"Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension","volume":"59","author":"Giunta","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/pcad.2002.129975_bib37","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(86)80301-1","article-title":"Antinuclear antibodies in primary pulmonary hypertension","volume":"8","author":"Rich","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.129975_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0889-857X(05)70335-5","article-title":"Pulmonary hypertension in systemic autoimmune disease","volume":"23","author":"Gurubhagavatula","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/pcad.2002.129975_bib39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/pcad.2002.129975_bib40","first-page":"1","article-title":"Pulmonary hypertension and systemic lupus erythematosus","volume":"13","author":"Asherson","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib41","first-page":"462","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib42","first-page":"2058","article-title":"Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus","volume":"21","author":"Yoshio","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib43","first-page":"1688","article-title":"Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis","volume":"22","author":"Fritzler","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1164\/ajrccm.155.1.9001324","article-title":"Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7","volume":"155","author":"Morse","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.129975_bib45","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.52.11.780","article-title":"Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone","volume":"52","author":"Martin","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/pcad.2002.129975_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.2000.01320.x","article-title":"Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35","volume":"121","author":"Grigolo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/pcad.2002.129975_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00695217","article-title":"Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature","volume":"404","author":"Ueda","year":"1984","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1053\/pcad.2002.129975_bib48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.129975_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9343(84)90783-6","article-title":"Raynaud's phenomenon of the lung","volume":"76","author":"Fahey","year":"1984","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.1780260815","article-title":"Vascular reactivity and pulmonary hypertension in systemic sclerosis","volume":"26","author":"Rozkovec","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1378\/chest.99.3.551","article-title":"Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension","volume":"99","author":"Morgan","year":"1991","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(85)90430-9","article-title":"Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis","volume":"78","author":"Shuck","year":"1985","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780380102","article-title":"Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone","volume":"38","author":"Kahaleh","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib54","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00002281-199611000-00011","article-title":"Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension","volume":"8","author":"Wigley","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1358836X0000500304","article-title":"Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma","volume":"5","author":"Romero","year":"2000","journal-title":"Vasc Med"},{"key":"10.1053\/pcad.2002.129975_bib56","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.129975_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8","article-title":"High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension","volume":"185","author":"Mason","year":"1998","journal-title":"J Pathol"},{"key":"10.1053\/pcad.2002.129975_bib58","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.52.12.1051","article-title":"Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension","volume":"52","author":"Kharitonov","year":"1997","journal-title":"Thorax"},{"key":"10.1053\/pcad.2002.129975_bib59","first-page":"1693","article-title":"Exhaled nitric oxide in systemic sclerosis: Relationships with lung involvement and pulmonary hypertension","volume":"27","author":"Rolla","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib60","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.129975_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9343(99)80157-0","article-title":"Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis","volume":"99","author":"Morelli","year":"1995","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2169\/internalmedicine.33.579","article-title":"Endothelin and collagen vascular disease: A review with special reference to Raynaud's phenomenon and systemic sclerosis","volume":"33","author":"Yamane","year":"1994","journal-title":"Intern Med"},{"issue":"suppl 1","key":"10.1053\/pcad.2002.129975_bib63","first-page":"48","article-title":"Relation of endothelin-1 to survival in patients with primary pulmonary hypertension","volume":"26","author":"Galie","year":"1996","journal-title":"Eur J Clin Investig"},{"key":"10.1053\/pcad.2002.129975_bib64","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/pcad.2002.129975_bib65","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.129975_bib66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.48.7.586","article-title":"Platelet serotonin in systemic sclerosis","volume":"48","author":"Klimiuk","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/pcad.2002.129975_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5273(88)90238-0","article-title":"Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon","volume":"19","author":"Biondi","year":"1988","journal-title":"Int J Cardiol"},{"key":"10.1053\/pcad.2002.129975_bib68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780390711","article-title":"Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma","volume":"39","author":"Stein","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","article-title":"Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis","volume":"36","author":"Denton","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib70","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.CIR.102.10.1145","article-title":"Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene","volume":"102","author":"Grunig","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.129975_bib71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/ard.52.10.725","article-title":"Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance","volume":"52","author":"Scheja","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/pcad.2002.129975_bib72","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/0002-9149(91)90330-N","article-title":"Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease","volume":"68","author":"Alpert","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1053\/pcad.2002.129975_bib73","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1378\/chest.98.3.759","article-title":"Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome","volume":"98","author":"Glikson","year":"1990","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib74","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0002-8703(85)90618-0","article-title":"Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis","volume":"109","author":"O'Brien","year":"1985","journal-title":"Am Heart J"},{"key":"10.1053\/pcad.2002.129975_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.129975_bib76","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9343(05)80003-8","article-title":"Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril","volume":"90","author":"Sfikakis","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.129975_bib77","first-page":"1763","article-title":"Combined effects of diltiazem and oxygen in pulmonary hypertension of mixed connective tissue disease","volume":"21","author":"Shinohara","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib78","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.102.5.1407","article-title":"Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease","volume":"102","author":"Alpert","year":"1992","journal-title":"Chest"},{"issue":"4 Pt 1","key":"10.1053\/pcad.2002.129975_bib79","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0002-8703(82)90020-5","article-title":"Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease","volume":"104","author":"Niarchos","year":"1982","journal-title":"Am Heart J"},{"key":"10.1053\/pcad.2002.129975_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.129975_bib81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"issue":"1 suppl","key":"10.1053\/pcad.2002.129975_bib82","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1378\/chest.114.1_Supplement.80S","article-title":"Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin)","volume":"114","author":"Humbert","year":"1998","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib83","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","article-title":"Systemic sclerosis-associated pulmonary hypertension: Short-and long-term effects of epoprostenol (prostacyclin)","volume":"42","author":"Klings","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib84","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O","article-title":"The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis","volume":"41","author":"Menon","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib86","first-page":"2252","article-title":"A.L. Fauchais, V. Queyrel, U. Mitchon-Pasturel, M. Hebbar, F. Saulnier, and Aerosolized iloprost in CREST syndrome related pulmonary hypertension","volume":"28","author":"Launay","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib87","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.129975_bib88","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial","volume":"39","author":"Galie","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.129975_bib89","first-page":"1195","article-title":"Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma","volume":"26","author":"Farber","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib91","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1378\/chest.121.2.656","article-title":"Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome","volume":"121","author":"Preston","year":"2002","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib92","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1148\/radiol.2223010668","article-title":"Pulmonary arterial hypertension: Thin-section CT predictors of epoprostenol therapy failure","volume":"222","author":"Resten","year":"2002","journal-title":"Radiology"},{"key":"10.1053\/pcad.2002.129975_bib93","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1164\/ajrccm.162.5.9912045","article-title":"Pulmonary veno-occlusive disease","volume":"162","author":"Mandel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.129975_bib94","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1378\/chest.118.4.1229","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"118","author":"Horn","year":"2000","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.129975_bib95","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.CIR.94.3.477","article-title":"Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension","volume":"94","author":"Williamson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.129975_bib96","first-page":"519","article-title":"Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis","volume":"14","author":"Seibold","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib97","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/147323000002800602","article-title":"Suppressive effect of sarpogrelate hydrochloride on respiratory failure and right ventricular failure with pulmonary hypertension in patients with systemic sclerosis","volume":"28","author":"Kato","year":"2000","journal-title":"J Int Med Res"},{"key":"10.1053\/pcad.2002.129975_bib98","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/030097400750002120","article-title":"Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange","volume":"29","author":"Ferri","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1053\/pcad.2002.129975_bib99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/pcad.2002.129975_bib100","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/1529-0131(200107)44:7<1660::AID-ART289>3.0.CO;2-W","article-title":"Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy","volume":"44","author":"Allcock","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1053\/pcad.2002.129975_bib101","first-page":"38","article-title":"White, Orens JB. Lung transplantation and systemic sclerosis","volume":"5","author":"Rosas","year":"2000","journal-title":"Ann Transplant"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306200270011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306200270011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T19:35:11Z","timestamp":1704742511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003306200270011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S003306200270011X"],"URL":"https:\/\/doi.org\/10.1053\/pcad.2002.129975","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}